Lawyer Close To Kavanaugh Said He Avoids Knee-Jerk Deference To FDA

By David Roza / July 12, 2018 at 8:23 PM
A lawyer familiar with Supreme Court nominee Brett Kavanaugh and his jurisprudence said the judge, should he be appointed to the high court, would avoid deferring automatically to FDA or other federal regulatory agencies on cases involving matters where Congress has not given clear instructions. Stuart Gerson, a member of the firm at Epstein Becker Green, a former acting U.S. Attorney General and an acquaintance of Kavanaugh's, told Inside Health Policy that Kavanaugh "is not striving to appeal the issue...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.